If you liked this article you might like

Jim Cramer -- Be Careful With Biogen; Apple Is Waking Up
Attention Shifts to Biogen's Alzheimer's Drug in Wake of Lilly Results
Stocks Extend Rally as Health Care Sector Makes Comeback
Biogen Shares Spike on Leaked Alzheimer's Drug Data